Form 4 for GILD Gilead Sciences
Accepted 2022-02-02 00:00:00 ET · period of report 2022-02-01 · accession 0001127602-22-003048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-02 | 2022-02-01 | GILD | Pletcher Brett A | EVP, Corp Affairs, Gen Counsel | S - Sale | $68.54 | -14.1K | 32.6K | -30% | -$963.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-01 | S | D | 14,061 | $68.54 | 32,576 | D | — | — | (F2) Sale prices reported for the transaction reported here range from $68.34 to $68.76. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |